Simethicone Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 40 mg
Reference Brands: Mylicon(US)
Category:
Gastrointestinal Drugs
Simethicone chewable tablets break down gas bubbles in the stomach and intestines, relieving bloating, pressure, and discomfort. They do not absorb into the bloodstream but work locally to improve digestion. Benefits include quick symptom relief, reduced bloating, enhanced comfort, and support for digestive health.
Simethicone tablet is available in Tablets
and strengths such as 40 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Simethicone tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Simethicone tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Simethicone chewable tablets, marketed as Mylicon in the US and as generic formulations in the EU, are approved as over-the-counter products for relief of gas, bloating, and indigestion. Regulatory approval requires a dossier including safety profiles, manufacturing standards, and labeling compliance. In the US, the FDA oversees OTC safety, while the EMA ensures safety and quality in Europe. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper compliance supports timely approval, safe use, and broad availability, helping consumers worldwide manage gastrointestinal discomfort effectively.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing